Joel L. Young, MD
- 2Articles
- 52.4KReads1
- 2016–2021Active
- 8Collaborators
- 36Citations2
About
Joel L. Young, MD, is affiliated with the Rochester Center for Behavioral Medicine in Rochester Hills, Michigan. His publications focus on neurodevelopmental psychiatry, particularly adult attention-deficit/hyperactivity disorder (ADHD). His work includes clinical trials evaluating amphetamine formulations and discussions on ADHD diagnosis, management, and treatment in the DSM-5 era. He has collaborated frequently with Andrew J. Cutler, Ann Childress, C. Brendan Montano, David W. Goodman, and Elias H. Sarkis.
Publications
Efficacy and Safety of AR19 in Adults With ADHD
August 24, 2021
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
